Trials / Terminated
TerminatedNCT02974140
Cataract Refractive Suite Study
A Prospective, Multicenter, Randomized Evaluation of Refractive Predictability in Patients With or Without Corneal Astigmatism (Maximum Allowable up to 1.25D) When Using the Cataract Refractive Suite and Standard Manual Techniques
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 39 (actual)
- Sponsor
- Alcon, a Novartis Company · Industry
- Sex
- All
- Age
- 22 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to compare the refractive predictability (prediction error) between the Cataract Refractive Suite (CRS) and standard manual technique at one month post-operative
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Cataract Refractive Suite (CRS) | Configuration consisting of Verion™ Image Guided System, LenSx® Laser and ORA™ System with VerifEye+™ (with or without VerifEye Lynk), combined for use in surgical pre-op planning and during cataract surgery |
| PROCEDURE | Standard manual technique | Standard biometry for intra-ocular lens (IOL) calculation and cataract removal using phacoemulsification technique |
Timeline
- Start date
- 2017-03-02
- Primary completion
- 2017-07-25
- Completion
- 2017-07-25
- First posted
- 2016-11-28
- Last updated
- 2018-09-14
- Results posted
- 2018-09-14
Locations
3 sites across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT02974140. Inclusion in this directory is not an endorsement.